ethylmaleimide and gemcitabine

ethylmaleimide has been researched along with gemcitabine in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M	1
Bepler, G; Chen, Z; Zhang, Y; Zhou, J	1

Other Studies

2 other study(ies) available for ethylmaleimide and gemcitabine

Article	Year
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology. Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3 Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries	2023
Modulation of the ribonucleotide reductase M1-gemcitabine interaction in vivo by N-ethylmaleimide. Biochemical and biophysical research communications, 2011, Sep-23, Volume: 413, Issue:2 Topics: Animals; Antimetabolites, Antineoplastic; Biomarkers, Pharmacological; Catalytic Domain; Cell Line, Tumor; Deoxycytidine; Drug Design; Drug Resistance, Neoplasm; Enzyme Inhibitors; Ethylmaleimide; Gemcitabine; Humans; Mice; Mice, Inbred Strains; Protein Conformation; Ribonucleoside Diphosphate Reductase; Tumor Suppressor Proteins; Xenograft Model Antitumor Assays	2011

Article

Year

In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.

Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023

Modulation of the ribonucleotide reductase M1-gemcitabine interaction in vivo by N-ethylmaleimide.

Biochemical and biophysical research communications, 2011, Sep-23, Volume: 413, Issue:2

Topics: Animals; Antimetabolites, Antineoplastic; Biomarkers, Pharmacological; Catalytic Domain; Cell Line, Tumor; Deoxycytidine; Drug Design; Drug Resistance, Neoplasm; Enzyme Inhibitors; Ethylmaleimide; Gemcitabine; Humans; Mice; Mice, Inbred Strains; Protein Conformation; Ribonucleoside Diphosphate Reductase; Tumor Suppressor Proteins; Xenograft Model Antitumor Assays

2011